Editor | Curator | Psychedelic Stock Review

Adding Ehave (EHVVF) to Psychedelic Stock Watch List.

CLINICAL TRIALS Editor | Curator - August 3, 2021

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low.Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical Trial With Mycotopia Therapies and PsyBioMed.Launching...

View Post

Able Partners

INVESTORS Editor | Curator - August 2, 2021

Able Partners Venture Capital People:Lisa Blau (Partner)Alison Ryu (Managing Director)Amanda Eilian (Partner) Location:New York, New York, USA

View Post

MindMed (MNMD)

LARGE CAP PSYCH Editor | Curator - August 1, 2021

PRESENTATION DECK - JUNE 2021 Decks contain forward-looking statements. All statements other than statements of historical...

View Post

NovaMind (CSE:NM, OTC:NVMDF) Presentation Deck.

CLINICS Editor | Curator - August 1, 2021

Presentation Deck LIVE QUOTE Canadian Chart Decks contain...

View Post

Revive Therapeutics (RVV:CN, RVVTF) Presentation Deck.

DECK Editor | Curator - July 30, 2021

PRESENTATION DECK - JULY 2021 LIVE QUOTE Decks...

View Post

Cybin (CLXPF CYBN) Banks $30 Million Overnight.

PSYCH STOCK NEWS Editor | Curator - July 28, 2021

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares. LIVE QUOTE

View Post

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

RESEARCH Editor | Curator - July 27, 2021

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT

View Post

Incredible Ibogaine Psychedelic’s Testimonial.

TESTIMONIALS Editor | Curator - July 27, 2021

TIME MAGAZINE: Marcus Capone, Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction Scroll down...

View Post